Sort by
Refine Your Search
-
Country
-
Field
-
at the Princess Máxima Center for Pediatric Oncology. You will lead the molecular characterization of astroblastoma, a newly recognized pediatric brain tumor type, using state-of-the-art multi-omics and integrative
-
position is based at the Center for Quantitative Genetics and Genomics (QGG) under the supervision of Asst. Prof. Irene Julca. The position is offered as a two-year appointment, with the possibility
-
Deutsches Zentrum für Neurodegenerative Erkrankungen | Magdeburg, Sachsen Anhalt | Germany | 10 days ago
, multi-site team Track record of peer-reviewed publications Fluent in written and spoken English; German is a strong plus, not a requirement Candidates who meet most, but not all
-
Description The Public Health Research Center at New York University Abu Dhabi is seeking a Post-Doctoral Associate in Population Genomics to work with the UAE Healthy Future Study, a cohort of
-
computational methods for the control, optimization, and coordination of complex dynamical systems. The work will emphasize applications to multi-agent systems, including robotics, autonomous systems, and
-
at the intersection of digital twins, multi-timescale system optimization, and integrated Power-to-X systems with special focus on the electrical engineering parts. This position offers a unique opportunity to drive
-
PALOC « Patrimoines locaux, environnement et globalisation » est une unité mixte de recherche pluridisciplinaire en sciences humaines et sociales, sous la triple tutelle de l’Institut de Recherche pour le
-
Post Doctoral Researcher / Senior Post Doctoral Researcher - School of Biochemistry and Cell Biology
analysis pipelines to deliver real-world translational outcomes and contribute to a multi-omics ovarian cancer knowledge base. Candidates should submit a motivation letter, CV with publications, and contact
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
the dynamics of therapy-resistance by combining advanced molecular biology method development to multi-omic single-cell analyses of both ex vivo models and clinical tumor specimens. Our novel, in-house